14/15 Next steps are Phase 3 pivotal trials to confirm efficacy and safety across larger, more diverse populations.
If successful, MM120 could become first novel GAD treatment in decades, offering hope to millions with treatment-resistant anxiety.
#Phase3 #FutureResearch